TCL Archive ASCO Annual Meeting: PARP Inhibitors Show Promise Against Breast Cancer In Small Phase II Studies June 5, 2009
TCL Archive OMB Restrictions On Reprogramming Could Result In Inefficient Last Minute Spending By Institutes September 13, 1985
TCL Archive Oncologists Don’t Demand Increased Survival When Ordering Expensive Drugs, Survey Finds April 13, 2012